Furthermore, pilot data from studies of UDCA treatment of women with intrahepatic cholestasis of pregnancy (ICP) have demonstrated reduced insulin resistance, indicating UDCA has the potential to be an effective treatment to improve maternal glycemia in GDM [32]. The gene discussed is INS; the disease is gestational diabetes.